Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENTAD-COVID: Autologous Stem Cells for COVID-19
NCT04473170Phase 2Completed
- Sponsor
- Abu Dhabi Stem Cells Center
- Start
- Apr 2020
- Primary completion
- May 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of UAECell19 in coronavirus disease 2019 (COVID-19), sponsored by Abu Dhabi Stem Cells Center. Started Apr 2020; status: completed.
02
Drugs
UAECell19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04473170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04473170.